Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jonathan Decarpentrie
Observed name:
J. Decarpentrie
Institutions:
University of Namur,
Namur Research Institute for Life Sciences
Observed institutions:
University of Namur,
Centre Hospitalier Universitaire de Clermont-Ferrand,
Namur Research Institute for Life Sciences,
UCLouvain
ORCID:
0000-0003-1110-3286
Observed ORCID:
0000-0003-1110-3286
OpenAlex ID:
A5092597572
Techniques for measuring NETosis: A critical literature review and outlook for standardization
2026
·
Constant Gillot
, Hachem Bouarroudj
, et al.
·
Thrombosis Research
·
8
Biom-03. Plasma Biomarkers for Non-invasive Glioblastoma Diagnosis: a Multimarker Strategy With Gfap, Uch-l1, Nfl, Tau, Mpo, and Pmn Elastase
2025
·
Jonathan Decarpentrie
, Clara David
, et al.
·
Neuro-Oncology
·
2
PDF
Biom-30. Cell Line Study of Nucleosome-based Biomarkers in the Diagnosis and Detection of Relapses in Glioblastoma
2023
·
Jonathan Decarpentrie
, Priscilla Van den Ackerveken
, et al.
·
Neuro-Oncology
·
2
PDF
Flow cytometry-based characterization of isolated human neutrophils: Evaluating viability, purity and defining a reference interval for basal activation in functional assays
2026
·
Hachem Bouarroudj
, Constant Gillot
, et al.
·
Journal of Immunological Methods
·
1
524P Cell line study of nucleosome-based biomarkers in the diagnosis and detection of relapses in glioblastoma
2023
·
J. Decarpentrie
, P. Van den Ackerveken
, et al.
·
Annals of Oncology
·
1
PDF
A multivariate plasma biomarker model for glioblastoma exclusion: a retrospective case-control study
2026
·
Jonathan Decarpentrie
, Clara David
, et al.
·
Translational Oncology
PDF
Evaluation of NETosis Inhibitors in a Laboratory-Developed ex-vivo Human Neutrophil Model
2026
·
Constant Gillot
, Pauline Michaux
, et al.
·
Journal of Inflammation Research
PDF
Toward a blood test for glioblastoma: a multivariate plasma biomarker model for a safe exclusion
2026
·
Jonathan Decarpentrie
, Clara David
, et al.
·
SSRN Electronic Journal
Toward a Blood Test for Glioblastoma: A Multivariate Plasma Biomarker Model for a Safe Exclusion
2026
·
Jonathan Decarpentrie
, Clara David
, et al.
·
SSRN Electronic Journal
Biom-26. Epigenetic Profiling of Patient-derived Glioblastoma Cells Using Nu.q® Immunoassays Reveals a Distinct Histone Modification Signature
2025
·
Jonathan Decarpentrie
, Priscilla Van den Ackerveken
, et al.
·
Neuro-Oncology
PDF
Biom-15. Cd142 Expression in Glioblastoma Cells as a Potential Biomarker for Thrombotic Risk Stratification
2025
·
Jonathan Decarpentrie
, Ninon Ghys
, et al.
·
Neuro-Oncology
PDF
GFAP, UCH-L1, TAU AND NFL as potential biomarkers for glioblastoma diagnosis and monitoring: A retrospective study
2024
·
Jonathan Decarpentrie
, Clara David
, et al.
·
The Journal of Liquid Biopsy
PDF
Sdps-13 Cell Line Study of Nucleosome-based Biomarkers in the Diagnosis and Detection of Relapses in Glioblastoma
2023
·
Jonathan Decarpentrie
, Priscilla Van den Ackerveken
, et al.
·
Neuro-Oncology Advances
PDF
Show more works
View as search
Works count:
13
Citation count:
14
H-index:
2
I10-index:
Year
Topic
Type